Login / Signup

How the COVID-19 Pandemic Impacted Oncological Molecular Diagnosis: A Picture from a National Reference Center for Molecular Pathology.

null Daniel PintoLuís Cirnesnull Regina PintoMaria João PinaGiancarlo TronconeFernando C. Schmitt
Published in: BioMed research international (2020)
Case reduction was observed at hospitals that have mostly been involved in the treatment of COVID-19 and in the north of the country, the region worst-hit by the pandemic. Similar to other studies, our TAT decreased, even with a similar number of routine cases. Thus, we conclude that it is possible to successfully adapt the workflow of a molecular pathology laboratory to new safety standards without losing efficiency.
Keyphrases
  • coronavirus disease
  • sars cov
  • healthcare
  • single molecule
  • prostate cancer
  • clinical practice
  • radical prostatectomy
  • minimally invasive